RNADerm Therapeutics
Berkeley, US · Founded 2018
Biotech
Founders & leadership
AK
Aaron K. SatoExecutive Officer, Director
MD
Mark de SouzaExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$750KraisedMar 2019 · 3 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.